Angiotensin-Converting Enzyme Inhibition as an Adjunct to Pulmonary Rehabilitation in COPD.

CONCLUSION: Use of the ACE-inhibitor enalapril alongside a programme of pulmonary rehabilitation, in patients without an established indication for ACE-inhibition, reduced the peak work rate response to exercise training in COPD patients. Clinical trial registration available at www.controlled-trials.com, ID ISRCTN79038750.
PMID: 27248440 [PubMed - as supplied by publisher]

Source: American Journal of Respiratory and Critical Care Medicine - May 31, 2016 Category: Respiratory Medicine Authors: Curtis KJ, Meyrick VM, Mehta B, Haji GS, Li K, Montgomery H, Man WD, Polkey MI, Hopkinson NS Tags: Am J Respir Crit Care Med Source Type: research